EXPERIENCE IN THE MANAGEMENT OF OCCLUSIVE DEEP VENUS THROMBOSIS WITH ENOXAPARININ SODIUM IN OUTPATIENT SETTINGS
| Autor: | A. M. ZUDIN, A. G. FAIBUSHEVICH |
|---|---|
| Jazyk: | ruština |
| Rok vydání: | 2017 |
| Předmět: |
antagonists of vitamin k
business.industry Deep vein Warfarin occlusive deep veins thrombosis General Medicine Heparin Vitamin k medicine.disease Thrombosis RC31-1245 enoxaparin sodium medicine.anatomical_structure Anesthesia Hemorrhagic complication medicine business Enoxaparin sodium Internal medicine medicine.drug |
| Zdroj: | Атеротромбоз, Vol 0, Iss 2, Pp 13-20 (2017) |
| ISSN: | 2658-5952 2307-1109 |
| Popis: | The article presents the experience in management of occlusive deep vein thrombosis with enoxaparin sodium in outpatient settings. The study included two groups of patients: the patients of the first group received unfractionated heparin for 10-14 days, followed by the treatment of patients with vitamin K antagonists (warfarin), and the patients of the second group also received enoxaparin sodium for 1 month with subsequent treatment with vitamin K antagonists. The study showed that the use of enoxaparin for the period of 1 month in combination with vitamin K antagonists significantly improved the results of treatment of these patients. It was also found that the use of enoxaparin sodium increased neither the risk of hemorrhagic complications nor the risk of thrombocytopenia. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|